RIKEN CDB
RIKEN CDB
phage P1 lox71, E. coli LacZ, poly A, yeast FRT (flipase recombination target) sites, mouse phosphoglycerate kinase (Pgk) promoter, E. coli neo, phage P1 loxP, rabbit beta-globin polyA, mouse Rspo2 genomic DNA
TT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1]
RBRC03512
C（3〜6か月）
Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: MTA for distribution with RIKEN BRC (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_5.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_c.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol>
FLP/frt system
R-spondin2(lacZ) (Acc.No. CDB0467K)
R-spondin2(lacZ) (Acc.No. CDB0467K)
<a href='https://brc.riken.jp/mus/pcr03512'>Genotyping protocol -PCR-</a>
Cre/loxP system
Developmental Biology Research
B6.Cg-Rspo2<tm1Hoka>/Rbrc
C (3-6 months)
条件を付加する。<br>(1) 分与希望者は事前に 岡本 仁 (hitoshi@brain.riken.jp) に連絡をとり、分与に関して許可を得ること。(2) 当該マウスを用いる論文発表に際してはAccession No. CDB0467K、そのWEB サイトhttp://www2.clst.riken.jp/arg/mutant%20mice%20list.htmlとともに当該マウスを記載すること。(3) 当該マウスを用いる論文発表に際しては、その由来として第一報論文 Dev Growth Differ. 2008 50(2):85-95. を引用すること。（4）発表論文を寄託者（mutant.bdr@riken.jp）に連絡すること。
Fluorescent Proteins/lacZ System
R-spondin2(lacZ) (Acc.No. CDB0467K)
true
(1) The RECIPIENT shall obtain a prior agreement from Dr. Hitoshi Okamoto (hitoshi@brain.riken.jp) to transfer the BIOLOGICAL RESOURCE. (2) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the Accession No. (CDB0467K) (http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) and the BIOLOGICAL RESOURCE is requested. (3) In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designed by the DEPOSITOR is requested. (Dev Growth Differ. 2008 50(2):85-95.) (4) Please inform the DEPOSITOR (mutant.bdr@riken.jp) about the paper when published.